Selective production of IL-33-neutralizing autoantibody ameliorates asthma responses and severity

Copyright © 2024 Elsevier Inc. All rights reserved.

Détails bibliographiques
Publié dans:Clinical immunology (Orlando, Fla.). - 1999. - 264(2024) vom: 15. Juli, Seite 110234
Auteur principal: Ji, Yuan (Auteur)
Autres auteurs: Wang, Eryi, Mohammed, Mohammed T, Hameed, Najwa, Christodoulou, Maria-Ioanna, Liu, Xiaoyu, Zhou, Wei, Fang, Zhangfu, Jia, Nan, Yu, Haiqiong, Zhou, Zhenwen, Sun, Ying, Huang, Shau-Ku, McSharry, Charles, Zhong, Nan-Shan, Xiao, Xiaojun, Li, Jing, Xu, Damo
Format: Article en ligne
Langue:English
Publié: 2024
Accès à la collection:Clinical immunology (Orlando, Fla.)
Sujets:Journal Article Anti-cytokine autoantibody Asthma IL-33 Prognosis Severity Autoantibodies Interleukin-33 Antibodies, Neutralizing Cytokines plus... IL33 protein, human Immunoglobulin E 37341-29-0 Toll-Like Receptor 9 Immunoglobulin G